Literature DB >> 19615314

[Therapy for replenishing qi, nourishing yin and promoting blood circulation in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial].

Sheng-lei Qiu1, Mei Jin, Jing-hong Yi, Tian-gang Zhu, Xin Quan, Yan Liang.   

Abstract

BACKGROUND: No-reflow phenomenon after reperfusion treatment of acute myocardial infarction (AMI) is becoming more recognized today. The effective treatment for no-reflow has not been reported.
OBJECTIVE: To observe the effects of traditional Chinese medicine (TCM) therapy for replenishing qi, nourishing yin, and promoting blood circulation on AMI patients undergoing percutaneous coronary intervention (PCI). DESIGN, SETTING, PARTICIPANTS AND
INTERVENTIONS: This study was conducted from January 2005 to March 2006 using a double-blinded, randomized method. Thirty-five AMI patients (Killip I-II) were first diagnosed as ST segment elevation AMI and obtained primary PCI. They were recruited from People's Hospital, Peking University. All patients' symptoms accorded with qi-yin deficiency syndrome and blood stasis syndrome. They were randomly and double blindly divided into control group (18 cases) and treatment group (17 cases). The patients in the control group received Western medicine treatment, and the patients in the treatment group were treated with Western medicine plus American ginseng and Salviae miltiorrhizae preparations. They were all treated for 3 months. MAIN OUTCOME MEASURES: Before and after 3-month treatment, the TCM symptoms were observed and scored. At the state of baseline and dobutamine stress, left ventricular ejection fraction (LVEF), wall motion score (WMS), WMS index and normal cardiac muscle percentage (NCMP), and the myocardial contrast echocardiography index k, which reflects myocardium microcirculation perfusion, were detected.
RESULTS: After 3-month treatment, the TCM symptoms in the treatment group were improved as compared with the control group (X(2)=4.118, P=0.042). At the state of dobutamine stress, LVEF in the treatment group after treatment was higher than those in the control group (t=2.130, P=0.041) and before treatment (t=2.345, P=0.032). Although the number of the segments with increased k value was more than that in the control group, there was no significant difference.
CONCLUSION: TCM therapy for replenishing qi, nourishing yin and promoting blood circulation can improve the clinical symptoms and quality of life of the AMI patients undergoing PCI, and is beneficial to myocardium microcirculation. Thus, it may be an alternative cardioprotective treatment strategy for successful myocardial microcirculation in AMI patients after reperfusion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19615314     DOI: 10.3736/jcim20090704

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  4 in total

1.  Analysis of the efficacy and safety of Danshen Dripping pills on the eyes of diabetic retinopathy patients with Qi stagnation and blood stasis.

Authors:  Fei Wang; Lianlian Li; Huizhen Xiao
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

2.  Traditional chinese herbal products for coronary heart disease: an overview of cochrane reviews.

Authors:  Yu Qiu; Hao Xu; Dazhuo Shi
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-28       Impact factor: 2.629

3.  Effect of wenxin granule on ventricular remodeling and myocardial apoptosis in rats with myocardial infarction.

Authors:  Aiming Wu; Jianying Zhai; Dongmei Zhang; Lixia Lou; Haiyan Zhu; Yonghong Gao; Limin Chai; Yanwei Xing; Xiying Lv; Lingqun Zhu; Mingjing Zhao; Shuoren Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-13       Impact factor: 2.629

4.  Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China.

Authors:  Erica S Spatz; Yongfei Wang; Adam L Beckman; Xuekun Wu; Yuan Lu; Xue Du; Jing Li; Xiao Xu; Patricia M Davidson; Frederick A Masoudi; John A Spertus; Harlan M Krumholz; Lixin Jiang
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.